Om

China Pharma Holdings, Inc. is a specialty pharmaceutical company focused on the development, manufacture, and marketing of human-use medicines in China. Its current portfolio covers products for central nervous system and cerebral-cardiovascular disorders, anti-infection and respiratory conditions, digestive diseases, comprehensive healthcare, and protective products. The company offers pharmaceuticals in multiple dosage forms, including injectables, tablets, capsules, and oral solutions, serving hospitals and private retailers across its domestic market. China Pharma Holdings, Inc. operates as a vertically integrated drug manufacturer, combining research, production, and commercialization within its business model. Based in Haikou, China, the company plays a role in supplying medicines for widely prevalent medical conditions in the Chinese healthcare market.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I CHINA PHARMA HOLDINGS MED ENDAVU: Køb China Pharma Holdings ($CPHI) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i China Pharma Holdings, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.